He’s a respected medical officer as well as a major mover and shaker in the area of healthcare reform. To those who know him personally, however, Dr. Sam Nussbaum is the wise and approachable “Dr. Sam.” The distinguished healthcare policy expert will be up on the podium at ASAP’s 2016 BioPharma Conference diagnosing woes and handing out prescriptions in relation to the changing political and healthcare scene in his talk “Healing the U.S. Health Care System: Collaboration is Essential” Wednesday, Sept. 7 at the conference “New Faces, Unexpected Places in Partnering: The Foresight to Lead, the Foundation to Succeed” at the Revere Hotel, Boston Common, Boston.
As a strategic consultant at EGB Advisors, Inc., the consulting arm for Epstein, Becker & Green, he advises healthcare, life science companies, physicians, hospitals, and provider organizations. He also served as the former executive vice president, clinical health policy, and chief medical officer at Anthem Health from 2000 to 2016, where he was acted as the key spokesperson and policy advocate and oversaw clinical strategy and corporate medical and pharmacy policy. He was responsible for HealthCore, Anthem's clinical outcomes research subsidiary, and helped create the model for the Food and Drug Administration’s Safety Sentinel System. Recognized by Modern Healthcare as one of the "50 Most Influential Physician Executives in Healthcare," he received the 2004 Physician Executive Award of Excellence from the American College of Physician Executives.
"Sam is the ‘advisor to healthcare advisors,’” says Brooke Paige, staff vice president, strategic initiatives at HealthCore, Inc. “He is sure to bring a dynamic energy and unique perspective to the ASAP Biopharma Conference. Sam is a true clinician, always keeping the patient in mind. As we talk about how our healthcare landscape may change in response to the upcoming presidential election, “Dr. Sam” can advise what potential election outcomes could mean for each segment of the industry."
Nussbaum is known for his exceptional role in creating collaborative solutions between Anthem, HealthCore, hospital systems, the FDA, and public agencies. He is well-versed in the value of partnering to solve systemic problems at the highest of levels, having helped design and promote patient-centered medical homes and assessed their impact on the quality and cost effectiveness of care. Under his leadership, HealthCore has built partnerships with federal agencies and academic institutions to advance drug safety, comparative effectiveness, and outcomes research.
“Dr. Nussbaum is uniquely qualified to discuss collaborative approaches and help attendees define ecosystem problems specific to their business while envisioning strategic partnering options to best address an alliance challenge,” says ASAP CEO Mike Leonetti, CSAP, of the choice. “We know as partnership professionals, that the US healthcare system will never be fixed without a collaborative approach—it's just too complex not to bring the payors, providers, industry, and government participants together. In addition, Nussbaum is a policy guru with strong healthcare policy experience and can help attendees prepare for a range of potential scenarios stemming from evolving healthcare policy impacted by the presidential elections.”
While serving at chief medical officer at WellPoint, he was accountable for $100 billion in healthcare expenditures—from clinical pharmacy programs to care and disease management. The HealthCore subsidiary built partnerships during that time to further outcomes research, drug safety, and comparative effectiveness with large federal agencies, such as the Centers for Disease Control and FDA, as well as academic institutions.
He received his medical degree from Mount Sinai School of Medicine, and trained in internal medicine at Stanford University Medical Center and Massachusetts General Hospital. He also trained in endocrinology and metabolism at Harvard Medical School and Massachusetts General Hospital. He currently serves on the Board of Directors of the OASIS Institute, NEHI, BioCrossroads (an Indiana-based public-private collaboration that advances and invests in the life sciences), and America's Agenda. He is a member of the Scientific Advisory Board of Medidata, a publicly traded clinical technology company serving life sciences clients, and the Healthcare Advisory Board of KPMG. He serves as Chair of the Centers for Education & Research on Therapeutics (CERTs) Steering Committee (a cooperative agreement between AHRQ and the FDA), is a member the HHS Health Care Payment Learning and Action Network (LAN) Guiding Committee, and participates in Institute of Medicine activities, including serving on the Roundtable on Value & Science-Driven Health Care.
For more information about the 2016 ASAP BioPharma Conference and keynote speaker Sam Nussbaum, go to http://www.asapweb.org/biopharma/.